All Stories

  1. Neutral impact of mTOR inhibitors on cardiovascular outcomes after kidney transplantation
  2. Interaction Between Frailty and Renal Function in Patients with Heart Failure
  3. The Role of Albuminuria in Diagnosing and Stratifying Kidney Disease in Heart Transplant Recipients: A KDIGO Criteria‐Based Analysis
  4. Protocol Biopsies Reveal Progressive Arteriolar Thickening as a Predictor of Mortality in Kidney Transplant Recipients
  5. Extracorporeal Photopheresis for Refractory BK Virus-Associated Nephropathy in Kidney Transplantation
  6. Lipid and immunophenotypic profiles in hemodialysis patients with citrate vs. acetate dialysates
  7. Implementación de la técnica interna (in-house) de determinación del ADN libre del donante en la actividad clínica diaria: experiencia del Hospital Clínic de Barcelona
  8. Implementation of the in-house technique for the determination of donor-derived cell-free DNA in daily clinical practice: Experience from the Hospital Clinic of Barcelona
  9. Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology
  10. Comparative Effects of Acetate- and Citrate-Based Dialysates on Dialysis Dose and Protein-Bound Uremic Toxins in Hemodiafiltration Patients: Exploring the Impact of Calcium and Magnesium Concentrations
  11. Lipid and Immunophenotypic Profiles in Hemodialysis Patients with Citrate vs. Acetate Dialysates
  12. Citrate Dialysate with and without Magnesium Supplementation in Hemodiafiltration: A Comparative Study Versus Acetate
  13. Editorial: CaRe Me: improving the cardio-renal-metabolic care of patients through clinical and translational research
  14. Citrate Dialysate with and without Magnesium Supplementation in Hemodiafiltration: A Comparative Study versus Acetate
  15. Comparación de la eficacia y seguridad de la nueva generación dializadores de helixona
  16. Correlación entre el sodio plasmático determinado por el laboratorio y el determinado por el monitor de hemodiálisis
  17. Tacrolimus’s Time Below Therapeutic Range Is Associated With Acute Pancreatic Graft Rejection and the Development of De Novo Donor-specific Antibodies
  18. Long-Term Outcomes of Incidental Liver Malignancies in Simultaneous Liver-Kidney Transplant Recipients
  19. Most recently developed polyester polymer alloy dialyzer: A new medium cut‐off membrane?
  20. Latest Trends in Hemodiafiltration
  21. Latest Trends in Hemodiafiltration
  22. Tricuspid regurgitation, right ventricular function, and renal congestion: a cardiorenal triangle
  23. Early kinetics of donor-derived cell-free DNA after transplantation predicts renal graft recovery and long-term function
  24. Practical implementation and clinical benefits of the new automated dialysate sodium control biosensor
  25. Comments on “Nonvalvular atrial fibrillation in patients undergoing chronic haemodialysis. Should dialysis patients with atrial fibrillation receive oral anticoagulation?”
  26. Comentarios a «Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?»
  27. Results of Salt Intake Restriction Monitored with the New Sodium Control Biosensor
  28. The metabolomic differential plasma profile between dialysates. Pursuing to understand the mechanisms of citrate dialysate clinical benefits
  29. Outcomes in older kidney recipients from older donors: A propensity score analysis
  30. Humoral and Cellular Immune Responses After a 3-dose Course of mRNA-1273 COVID-19 Vaccine in Kidney Transplant Recipients: A Prospective Cohort Study
  31. Impact of Acetate versus Citrate Dialysates on Intermediary Metabolism—A Targeted Metabolomics Approach
  32. Lipidic profiles of patients starting peritoneal dialysis suggest an increased cardiovascular risk beyond classical dyslipidemia biomarkers
  33. Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment
  34. Comparison of four medium cut-off dialyzers
  35. Multimodal Strategies for the Diagnosis and Management of Refractory Congestion. An Integrated Cardiorenal Approach
  36. Safety profile and clinical results of Remdesivir in Hemodialysis patients infected with SARS-CoV-2. A single-center Spanish cohort study
  37. Efficacy and Safety of the Medium Cut-Off Elisio HX Dialyzer
  38. Tailoring the dialysate bicarbonate eliminates pre-dialysis acidosis and post-dialysis alkalosis
  39. Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients
  40. Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients
  41. Cloudy fluid, cloudy diagnosis
  42. Antiphospholipase A2 receptor antibody-positive membranous nephropathy in the kidney donor: Lessons from a serendipitous transplantation
  43. The Case | Persistent fever in a hemodialysis patient
  44. Lipidic Profiles of Patients Starting Peritoneal Dialysis Suggest an Increased Cardiovascular Risk Beyond Classical Dyslipidemia Biomarkers
  45. Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients
  46. Antibody maintenance 3 months after complete messenger RNA COVID-19 vaccination in haemodialysis patients
  47. Acute hepatitis post arteriovenous graft thrombectomy of hemodialysis vascular access
  48. Weekly seroconversion rate of the mRNA-1273 SARS-CoV-2 vaccine in haemodialysis patients
  49. Efficacy and safety of the Clearum dialyzer
  50. Fatal SARS-CoV-2 reinfection in an immunosuppressed patient on hemodialysis
  51. Rapid re‐transplantation safety following early kidney graft loss
  52. Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
  53. Accelerated cellular rejection with prominent interstitial hemorrhage following cemiplimab treatment: How can we approach a renal transplant recipient under anti-PD1 therapy?
  54. Evaluation and comparison of polysulfone TS‐UL and PMMA NF‐U dialyzers versus expanded hemodialysis and postdilution hemodiafiltration
  55. Humoral response of mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
  56. A case of recurrent anemia due to chronic parvovirus B19 infection in a kidney transplant recipient. Can everolimus make a difference?
  57. SARS-CoV-2 Infection in a Spanish Cohort of CKD-5D Patients: Prevalence, Clinical Presentation, Outcomes, and De-Isolation Results
  58. Prevalence of COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening
  59. Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL)
  60. Optimization of dialysate bicarbonate in patients treated with online haemodiafiltration
  61. Preliminary data on outcomes of SARS‐CoV‐2 infection in a Spanish single center cohort of kidney recipients
  62. Case report of COVID‐19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?
  63. Comparison of Solute Removal Properties Between High‐Efficient Dialysis Modalities in Low Blood Flow Rate